| Name | Title | Contact Details |
|---|
Farmigo brings the farmers market online, connecting food communities -- such as workplaces, apartment complexes, community centers and schools -- directly to multiple local farms to provide a personalized online marketplace for fresh-from-harvest food. The Farmigo team is dedicated to accelerating the adoption of an alternative food system by delivering healthy locally grown food to households across the country.
The Bazooka Companies, Inc. has been a leader in non-chocolate candy around the world since 1938 with popular, high-quality lollipop brands Ring Pop®, Push Pop®, Baby Bottle Pop®, Juicy Drop® and other candy and gum products, including the iconic Bazooka® Bubble Gum. The Bazooka Companies, Inc. was originally founded as Topps Chewing Gum and in its early years produced a popular penny Topps Gum from a factory in Brooklyn, N.Y. After World War II, the company developed Bazooka Bubble Gum and in 1950, added trading cards to its product line. The company was acquired in October 2007 by Madison Dearborn Partners, a private equity group, and Michael Eisner, former CEO of Disney, and is headquartered in New York City.
"Its what real chicken tastes like"
Delivering delicious prepared meals that adhere to Paleo, gluten-free, dairy-free, anti-inflammatory and organic diets throughout Chicago and suburbs.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.